nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Iodide—Polyp—Vandetanib—thyroid cancer	0.0311	0.0311	CcSEcCtD
Potassium Iodide—Hypothyroidism—Vandetanib—thyroid cancer	0.0294	0.0294	CcSEcCtD
Potassium Iodide—Cyst—Vandetanib—thyroid cancer	0.0283	0.0283	CcSEcCtD
Potassium Iodide—Ileus—Vandetanib—thyroid cancer	0.0267	0.0267	CcSEcCtD
Potassium Iodide—Endocrine disorder—Vandetanib—thyroid cancer	0.0228	0.0228	CcSEcCtD
Potassium Iodide—Hypothyroidism—Sorafenib—thyroid cancer	0.0199	0.0199	CcSEcCtD
Potassium Iodide—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.0175	0.0175	CcSEcCtD
Potassium Iodide—Leukaemia—Epirubicin—thyroid cancer	0.0175	0.0175	CcSEcCtD
Potassium Iodide—Neoplasm—Vandetanib—thyroid cancer	0.0171	0.0171	CcSEcCtD
Potassium Iodide—Leukaemia—Doxorubicin—thyroid cancer	0.0162	0.0162	CcSEcCtD
Potassium Iodide—Endocrine disorder—Sorafenib—thyroid cancer	0.0154	0.0154	CcSEcCtD
Potassium Iodide—Neoplasm malignant—Sorafenib—thyroid cancer	0.0149	0.0149	CcSEcCtD
Potassium Iodide—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.0137	0.0137	CcSEcCtD
Potassium Iodide—Cardiac arrest—Vandetanib—thyroid cancer	0.013	0.013	CcSEcCtD
Potassium Iodide—Nasopharyngitis—Vandetanib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Potassium Iodide—Neoplasm—Sorafenib—thyroid cancer	0.0115	0.0115	CcSEcCtD
Potassium Iodide—Haemoglobin—Vandetanib—thyroid cancer	0.00954	0.00954	CcSEcCtD
Potassium Iodide—Haemorrhage—Vandetanib—thyroid cancer	0.00949	0.00949	CcSEcCtD
Potassium Iodide—Eye disorder—Vandetanib—thyroid cancer	0.00887	0.00887	CcSEcCtD
Potassium Iodide—Cardiac disorder—Vandetanib—thyroid cancer	0.00881	0.00881	CcSEcCtD
Potassium Iodide—Venous thrombosis—Epirubicin—thyroid cancer	0.00873	0.00873	CcSEcCtD
Potassium Iodide—Arrhythmia—Vandetanib—thyroid cancer	0.00848	0.00848	CcSEcCtD
Potassium Iodide—Abdominal pain upper—Sorafenib—thyroid cancer	0.00845	0.00845	CcSEcCtD
Potassium Iodide—Nasopharyngitis—Sorafenib—thyroid cancer	0.00828	0.00828	CcSEcCtD
Potassium Iodide—Dysgeusia—Vandetanib—thyroid cancer	0.00809	0.00809	CcSEcCtD
Potassium Iodide—Venous thrombosis—Doxorubicin—thyroid cancer	0.00808	0.00808	CcSEcCtD
Potassium Iodide—Polyp—Epirubicin—thyroid cancer	0.00775	0.00775	CcSEcCtD
Potassium Iodide—Abdominal discomfort—Sorafenib—thyroid cancer	0.00767	0.00767	CcSEcCtD
Potassium Iodide—Eruption—Epirubicin—thyroid cancer	0.00766	0.00766	CcSEcCtD
Potassium Iodide—Cough—Vandetanib—thyroid cancer	0.00721	0.00721	CcSEcCtD
Potassium Iodide—Polyp—Doxorubicin—thyroid cancer	0.00717	0.00717	CcSEcCtD
Potassium Iodide—Eruption—Doxorubicin—thyroid cancer	0.00709	0.00709	CcSEcCtD
Potassium Iodide—Cyst—Epirubicin—thyroid cancer	0.00705	0.00705	CcSEcCtD
Potassium Iodide—Chest pain—Vandetanib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Potassium Iodide—Arthralgia—Vandetanib—thyroid cancer	0.00703	0.00703	CcSEcCtD
Potassium Iodide—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00699	0.00699	CcSEcCtD
Potassium Iodide—Bone marrow depression—Epirubicin—thyroid cancer	0.00698	0.00698	CcSEcCtD
Potassium Iodide—Infection—Vandetanib—thyroid cancer	0.0067	0.0067	CcSEcCtD
Potassium Iodide—Ileus—Epirubicin—thyroid cancer	0.00666	0.00666	CcSEcCtD
Potassium Iodide—Thrombocytopenia—Vandetanib—thyroid cancer	0.0066	0.0066	CcSEcCtD
Potassium Iodide—Skin disorder—Vandetanib—thyroid cancer	0.00655	0.00655	CcSEcCtD
Potassium Iodide—Cyst—Doxorubicin—thyroid cancer	0.00652	0.00652	CcSEcCtD
Potassium Iodide—Bone marrow depression—Doxorubicin—thyroid cancer	0.00646	0.00646	CcSEcCtD
Potassium Iodide—Haemoglobin—Sorafenib—thyroid cancer	0.00644	0.00644	CcSEcCtD
Potassium Iodide—Haemorrhage—Sorafenib—thyroid cancer	0.0064	0.0064	CcSEcCtD
Potassium Iodide—Ileus—Doxorubicin—thyroid cancer	0.00616	0.00616	CcSEcCtD
Potassium Iodide—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00614	0.00614	CcSEcCtD
Potassium Iodide—Paraesthesia—Vandetanib—thyroid cancer	0.00606	0.00606	CcSEcCtD
Potassium Iodide—Cardiac disorder—Sorafenib—thyroid cancer	0.00594	0.00594	CcSEcCtD
Potassium Iodide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00582	0.00582	CcSEcCtD
Potassium Iodide—Fatigue—Vandetanib—thyroid cancer	0.00581	0.00581	CcSEcCtD
Potassium Iodide—Pain—Vandetanib—thyroid cancer	0.00577	0.00577	CcSEcCtD
Potassium Iodide—Arrhythmia—Sorafenib—thyroid cancer	0.00572	0.00572	CcSEcCtD
Potassium Iodide—Blood disorder—Epirubicin—thyroid cancer	0.00564	0.00564	CcSEcCtD
Potassium Iodide—Neoplasm malignant—Epirubicin—thyroid cancer	0.00552	0.00552	CcSEcCtD
Potassium Iodide—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00551	0.00551	CcSEcCtD
Potassium Iodide—Dysgeusia—Sorafenib—thyroid cancer	0.00546	0.00546	CcSEcCtD
Potassium Iodide—Extravasation—Epirubicin—thyroid cancer	0.0054	0.0054	CcSEcCtD
Potassium Iodide—Abdominal pain—Vandetanib—thyroid cancer	0.00533	0.00533	CcSEcCtD
Potassium Iodide—Body temperature increased—Vandetanib—thyroid cancer	0.00533	0.00533	CcSEcCtD
Potassium Iodide—Blood disorder—Doxorubicin—thyroid cancer	0.00522	0.00522	CcSEcCtD
Potassium Iodide—Anaemia—Sorafenib—thyroid cancer	0.00515	0.00515	CcSEcCtD
Potassium Iodide—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00511	0.00511	CcSEcCtD
Potassium Iodide—Angioedema—Sorafenib—thyroid cancer	0.00509	0.00509	CcSEcCtD
Potassium Iodide—Extravasation—Doxorubicin—thyroid cancer	0.005	0.005	CcSEcCtD
Potassium Iodide—Leukopenia—Sorafenib—thyroid cancer	0.00499	0.00499	CcSEcCtD
Potassium Iodide—Dysarthria—Epirubicin—thyroid cancer	0.00498	0.00498	CcSEcCtD
Potassium Iodide—Ulcer—Epirubicin—thyroid cancer	0.00498	0.00498	CcSEcCtD
Potassium Iodide—Cough—Sorafenib—thyroid cancer	0.00486	0.00486	CcSEcCtD
Potassium Iodide—Atrioventricular block—Epirubicin—thyroid cancer	0.00486	0.00486	CcSEcCtD
Potassium Iodide—Asthenia—Vandetanib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Potassium Iodide—Pruritus—Vandetanib—thyroid cancer	0.00477	0.00477	CcSEcCtD
Potassium Iodide—Arthralgia—Sorafenib—thyroid cancer	0.00475	0.00475	CcSEcCtD
Potassium Iodide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00471	0.00471	CcSEcCtD
Potassium Iodide—Hyperkalaemia—Epirubicin—thyroid cancer	0.00463	0.00463	CcSEcCtD
Potassium Iodide—Diarrhoea—Vandetanib—thyroid cancer	0.00461	0.00461	CcSEcCtD
Potassium Iodide—Dysarthria—Doxorubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Potassium Iodide—Ulcer—Doxorubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Potassium Iodide—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00458	0.00458	CcSEcCtD
Potassium Iodide—Infection—Sorafenib—thyroid cancer	0.00452	0.00452	CcSEcCtD
Potassium Iodide—Atrioventricular block—Doxorubicin—thyroid cancer	0.00449	0.00449	CcSEcCtD
Potassium Iodide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00445	0.00445	CcSEcCtD
Potassium Iodide—Skin disorder—Sorafenib—thyroid cancer	0.00442	0.00442	CcSEcCtD
Potassium Iodide—Vomiting—Vandetanib—thyroid cancer	0.00429	0.00429	CcSEcCtD
Potassium Iodide—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00428	0.00428	CcSEcCtD
Potassium Iodide—Neoplasm—Epirubicin—thyroid cancer	0.00426	0.00426	CcSEcCtD
Potassium Iodide—Rash—Vandetanib—thyroid cancer	0.00425	0.00425	CcSEcCtD
Potassium Iodide—Dermatitis—Vandetanib—thyroid cancer	0.00425	0.00425	CcSEcCtD
Potassium Iodide—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00423	0.00423	CcSEcCtD
Potassium Iodide—Headache—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Potassium Iodide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00414	0.00414	CcSEcCtD
Potassium Iodide—Lymphadenopathy—Epirubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Potassium Iodide—Nausea—Vandetanib—thyroid cancer	0.00401	0.00401	CcSEcCtD
Potassium Iodide—Phlebitis—Epirubicin—thyroid cancer	0.00397	0.00397	CcSEcCtD
Potassium Iodide—Neoplasm—Doxorubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Potassium Iodide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00393	0.00393	CcSEcCtD
Potassium Iodide—Fatigue—Sorafenib—thyroid cancer	0.00392	0.00392	CcSEcCtD
Potassium Iodide—Pain—Sorafenib—thyroid cancer	0.00389	0.00389	CcSEcCtD
Potassium Iodide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00372	0.00372	CcSEcCtD
Potassium Iodide—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Potassium Iodide—Phlebitis—Doxorubicin—thyroid cancer	0.00367	0.00367	CcSEcCtD
Potassium Iodide—Urticaria—Sorafenib—thyroid cancer	0.00361	0.00361	CcSEcCtD
Potassium Iodide—Abdominal pain—Sorafenib—thyroid cancer	0.0036	0.0036	CcSEcCtD
Potassium Iodide—Body temperature increased—Sorafenib—thyroid cancer	0.0036	0.0036	CcSEcCtD
Potassium Iodide—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Potassium Iodide—Hypersensitivity—Sorafenib—thyroid cancer	0.00335	0.00335	CcSEcCtD
Potassium Iodide—Asthenia—Sorafenib—thyroid cancer	0.00326	0.00326	CcSEcCtD
Potassium Iodide—Cardiac arrest—Epirubicin—thyroid cancer	0.00325	0.00325	CcSEcCtD
Potassium Iodide—Pruritus—Sorafenib—thyroid cancer	0.00322	0.00322	CcSEcCtD
Potassium Iodide—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00317	0.00317	CcSEcCtD
Potassium Iodide—Abdominal pain upper—Epirubicin—thyroid cancer	0.00312	0.00312	CcSEcCtD
Potassium Iodide—Diarrhoea—Sorafenib—thyroid cancer	0.00311	0.00311	CcSEcCtD
Potassium Iodide—Nasopharyngitis—Epirubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Potassium Iodide—Cardiac arrest—Doxorubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Potassium Iodide—Eosinophilia—Epirubicin—thyroid cancer	0.00293	0.00293	CcSEcCtD
Potassium Iodide—Vomiting—Sorafenib—thyroid cancer	0.00289	0.00289	CcSEcCtD
Potassium Iodide—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Potassium Iodide—Rash—Sorafenib—thyroid cancer	0.00287	0.00287	CcSEcCtD
Potassium Iodide—Dermatitis—Sorafenib—thyroid cancer	0.00287	0.00287	CcSEcCtD
Potassium Iodide—Headache—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Potassium Iodide—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Potassium Iodide—Pancytopenia—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Potassium Iodide—Eosinophilia—Doxorubicin—thyroid cancer	0.00271	0.00271	CcSEcCtD
Potassium Iodide—Nausea—Sorafenib—thyroid cancer	0.0027	0.0027	CcSEcCtD
Potassium Iodide—Pancytopenia—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Potassium Iodide—Haemoglobin—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Potassium Iodide—Rhinitis—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Potassium Iodide—Haemorrhage—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Potassium Iodide—Hypoaesthesia—Epirubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Potassium Iodide—Eye disorder—Epirubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Potassium Iodide—Haemoglobin—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Potassium Iodide—Cardiac disorder—Epirubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Potassium Iodide—Rhinitis—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Potassium Iodide—Haemorrhage—Doxorubicin—thyroid cancer	0.00219	0.00219	CcSEcCtD
Potassium Iodide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Potassium Iodide—Arrhythmia—Epirubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Potassium Iodide—Eye disorder—Doxorubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Potassium Iodide—Cardiac disorder—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Potassium Iodide—Flatulence—Epirubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Potassium Iodide—Dysgeusia—Epirubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Potassium Iodide—Arrhythmia—Doxorubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Potassium Iodide—Anaemia—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Potassium Iodide—Flatulence—Doxorubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Potassium Iodide—Dysgeusia—Doxorubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Potassium Iodide—Malaise—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Potassium Iodide—Leukopenia—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Potassium Iodide—Cough—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Potassium Iodide—Anaemia—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Potassium Iodide—Arthralgia—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Potassium Iodide—Chest pain—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Potassium Iodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Potassium Iodide—Discomfort—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Potassium Iodide—Malaise—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Potassium Iodide—Leukopenia—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Potassium Iodide—Confusional state—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Potassium Iodide—Infection—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Potassium Iodide—Cough—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Potassium Iodide—Thrombocytopenia—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Potassium Iodide—Tachycardia—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Potassium Iodide—Skin disorder—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Potassium Iodide—Arthralgia—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Potassium Iodide—Chest pain—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Potassium Iodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Potassium Iodide—Discomfort—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Potassium Iodide—Hypotension—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Potassium Iodide—Confusional state—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Potassium Iodide—Infection—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Potassium Iodide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Potassium Iodide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Potassium Iodide—Tachycardia—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Potassium Iodide—Skin disorder—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Potassium Iodide—Paraesthesia—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Potassium Iodide—Hypotension—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Potassium Iodide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Potassium Iodide—Fatigue—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Potassium Iodide—Pain—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Potassium Iodide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Potassium Iodide—Paraesthesia—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Potassium Iodide—Feeling abnormal—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Potassium Iodide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Potassium Iodide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Potassium Iodide—Fatigue—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Potassium Iodide—Urticaria—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Potassium Iodide—Pain—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Potassium Iodide—Abdominal pain—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Potassium Iodide—Body temperature increased—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Potassium Iodide—Feeling abnormal—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Potassium Iodide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Potassium Iodide—Hypersensitivity—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Potassium Iodide—Urticaria—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Potassium Iodide—Body temperature increased—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Potassium Iodide—Abdominal pain—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Potassium Iodide—Asthenia—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Potassium Iodide—Pruritus—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Potassium Iodide—Diarrhoea—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Potassium Iodide—Hypersensitivity—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Potassium Iodide—Asthenia—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Potassium Iodide—Pruritus—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Potassium Iodide—Vomiting—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Potassium Iodide—Diarrhoea—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Potassium Iodide—Rash—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Potassium Iodide—Dermatitis—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Potassium Iodide—Headache—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Potassium Iodide—Nausea—Epirubicin—thyroid cancer	0.000999	0.000999	CcSEcCtD
Potassium Iodide—Vomiting—Doxorubicin—thyroid cancer	0.000989	0.000989	CcSEcCtD
Potassium Iodide—Rash—Doxorubicin—thyroid cancer	0.000981	0.000981	CcSEcCtD
Potassium Iodide—Dermatitis—Doxorubicin—thyroid cancer	0.00098	0.00098	CcSEcCtD
Potassium Iodide—Headache—Doxorubicin—thyroid cancer	0.000975	0.000975	CcSEcCtD
Potassium Iodide—Nausea—Doxorubicin—thyroid cancer	0.000924	0.000924	CcSEcCtD
